Dominic Allocco
Overview
Explore the profile of Dominic Allocco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
66
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alli O, Garg J, Boursiquot B, Kapadia S, Yeh R, Price M, et al.
J Am Heart Assoc
. 2024 Nov;
13(23):e036406.
PMID: 39575715
Background: Left atrial appendage occlusion (LAAO) is increasingly used as an alternative to oral anticoagulation for stroke prevention in select patients with atrial fibrillation. Data on outcomes in racial and...
2.
Kyllo T, Allocco D, Hei L, Wulff H, Erickson J
Front Pharmacol
. 2024 Nov;
15:1466953.
PMID: 39539628
Background: Riluzole exhibits neuroprotective and therapeutic effects in several neurological disease models associated with excessive synaptic glutamate (Glu) release. We recently showed riluzole prevents acute excitotoxic hippocampal neural injury at...
3.
Epps K, Goel R, Mehran R, Kandzari D, Damluji A, Tehrani B, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Mar;
2(5).
PMID: 38469035
Background: How diabetes mellitus (DM), race/ethnicity, and sex impact ischemic events following coronary artery stent procedures is unknown. Methods: Using the PLATINUM Diversity and PROMUS Element Plus Post-Approval Pooled Study...
4.
Mihatov N, Kirtane A, Stoler R, Feldman R, Neumann F, Boutis L, et al.
Am J Cardiol
. 2023 Oct;
207:370-379.
PMID: 37778226
The EVOLVE Short DAPT study demonstrated the safety of truncated dual antiplatelet therapy (DAPT) in patients with a high bleeding risk (HBR) treated with SYNERGY stent(s) (Boston Scientific Company, Marlborough,...
5.
Kim W, Thiele H, Linke A, Kuntze T, Fichtlscherer S, Webb J, et al.
J Interv Cardiol
. 2022 Jul;
2022:9138403.
PMID: 35832535
Objectives: The PROGRESS PVL registry evaluated transcatheter aortic valve implantation (TAVI) in patients treated with ACURATE , a supra-annular self-expanding bioprosthetic aortic valve. Background: While clinical outcomes with TAVI are...
6.
Karmpaliotis D, Stoler R, Walsh S, El-Jack S, Potluri S, Moses J, et al.
Catheter Cardiovasc Interv
. 2021 May;
99(2):373-380.
PMID: 34051049
Objectives: The EVOLVE 48 study evaluated the safety and effectiveness of the SYNERGY 48 mm stent for the treatment of long lesions. Background: Clinical evidence supporting the use of very...
7.
Kirtane A, Stoler R, Feldman R, Neumann F, Boutis L, Tahirkheli N, et al.
Circ Cardiovasc Interv
. 2021 Mar;
14(3):e010144.
PMID: 33641374
[Figure: see text].
8.
Sedaghat A, Nickenig G, Schrickel J, Ince H, Schmidt B, Protopopov A, et al.
Catheter Cardiovasc Interv
. 2021 Jan;
97(7):E1019-E1024.
PMID: 33417282
Background: In this analysis of the EWOLUTION registry, we evaluated the incidence, relevance and predictors of device-related thrombus in a large multi-center real-world cohort undergoing LAAc with the WATCHMAN device....
9.
Guedeney P, Claessen B, Mehran R, Kandzari D, Aquino M, Davis S, et al.
Catheter Cardiovasc Interv
. 2019 Jan;
94(1):82-90.
PMID: 30666784
Objective: We evaluated 1-year outcomes after platinum chromium everolimus-eluting stents (PtCr-EES) in small versus non-small coronary arteries within a large, diverse sample of men, women, and minorities. Background: There exists...
10.
van Gils L, Wohrle J, Hildick-Smith D, Bleiziffer S, Blackman D, Abdel-Wahab M, et al.
JACC Cardiovasc Interv
. 2018 Jan;
11(2):119-128.
PMID: 29348006
Objectives: The aim of this post hoc analysis from the RESPOND (Repositionable Lotus Valve System-Post-Market Evaluation of Real World Clinical Outcomes) post-market study was to assess the final implantation depth...